Market Cap 2.65M
Revenue (ttm) 1.10M
Net Income (ttm) -22.94M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,085.45%
Debt to Equity Ratio 0.00
Volume 12,371
Avg Vol 172,268
Day's Range N/A - N/A
Shares Out 5.09M
Stochastic %K 56%
Beta 1.53
Analysts Hold
Price Target $50.00

Latest News on MTNB

Matinas BioPharma Receives NYSE Noncompliance Notice

Jan 10, 2025, 5:15 PM EST - 2 months ago

Matinas BioPharma Receives NYSE Noncompliance Notice


Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

Oct 12, 2023, 11:26 AM EDT - 1 year ago

Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

ANVS AVTX TPST